Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life;Efeitos do tratamento do hipotiroidismo subclínico sobre sintomas psiquiátricos, queixas musculares e qualidade de vida

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 56, Issue 2, 2012, Pages 128-136

  Reuters, Vaneska Spinelli ^a   Almeida, Cloyra de Paiva ^a   Teixeira, Patrícia de Fátima dos Santos ^a   Vigário, Patrícia dos Santos ^a   Ferreira, Márcia Martins ^a   de Castro, Carmen Lucia Natividade ^a   Brasil, Marco Antônio ^a   da Costa, Antônio José Leal ^a   Buescu, Alexandru ^a   Vaisman, Mário ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anxiety; Depression; Levothyroxine; Quality of life

Indexed keywords

EID: 84861311290     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302012000200006     Document Type: Article

References (42)

1. Kaminsky P, Klein M, Duc M. [Hypothyroid myopathy. Physiopathological approach]. Ann Endocrinol. 1992;53(4):125-32.
2. Horak HA, Pourmand R. Endocrine myopathies. Neurol Clin. 2000;18(1):203-13.
3. Eustatia-Rutten CFA, Corssmit EPM, Pereira AM, Frolicht M, Bax J, Romijn JJA. Quality of life in long term exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol. 2006;64(3):284-91.
4. Hendrick VC, Garrick TR. Endocrine and metabolic disorder. In: Kaplan, Sadock's (editors). Comprehensive Textbook of Psychiatry. 7th Ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 1808-13.
5. Smith JW, Evans AT, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev. 2002;26(1):45-60.
6. Cooper DS, Biondi B. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76-131.
7. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med. 1984;101(1):18-24.
8. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92(6):631-42.
9. Canaris GJ, Manowitz NR, Mayor G, Ridgway C. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34.
10. Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med. 2002;112(1):348-54.
11. Reuters VS, Buescu A, Reis FA, Almeida CP, Teixeira PF, Costa AJ, et al. avaliação clínica e da função muscular em pacientes com hipotireoidismo subclínico. Arq Bras Endocrinol Metabol. 2006;50(3):523-30.
12. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res. 2004;13(1):45-54.
13. Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf). 66(4):548-56.
14. Gulseren S, Gulseren L, Hekimsoy Z, Certinary P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid function. Arch Med Res. 2006;37(1):133-9.
15. Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T 4 replacement therapy. Clin Endocrinol. 1999;51(2):237-42.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
17. Hamilton M. The Assessment of Anxiety States by Rating. Br J Med Psychol. 1959;32:50-5.
18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An Inventory for Measuring Depression. Arch Gen Psychiatry. 1961;41(4):561-71.
19. Zulewski H, Muller B, Exer P, Miserez AR, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82(3):771-6.
20. Ciconelli RM, Ferraz MB, Santos W. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol. 1999;39:143-50.
21. Daniels L, Worthingham C. Muscle Testing Techniques of Manual Examination. 3rd ed. Philadelphia: WB Saunders Co; 1972. p. 50-4.
22. Reuters VS, Teixeira PFS, Vigário PS, Almeida CP, Buescu A, Ferreira MM, et al. Exercise tolerance and muscular abnormalities in subclinical hypothyroidism. Am J Med Sci. 2009;338(4):259-63.
23. The National Isometric Muscle Strength (NIMS) Database Consortium. Muscular weakness assessment: use of normal isometric strength data. Arch Phys Med Rehabil. 1996;77:1251-5.
24. Riddoch G, Rowley BW, Cairns HWB. Aids to the investigation of peripheral nerve Injuries. Medical Research Council, London: HM Stationery Office; 1943.
25. Picado C, Fiz JA, Montserrat JM, Grau JM, Fernandez-Sola J, Luengo MT, et al. Respiratory and skeletal muscle function in steroid-dependent bronchial asthma. Am Rev Respir Dis. 1990;141(1):14-20.
26. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and Sex. Am Rev Respir Dis. 1969;99:696-702.
27. Bono G, Fancellu R, Blandini F, Santoro G, Mauri M. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand. 2004;110 (1):59-66.
28. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab. 2006;91(1):145-53.
29. Jensovsky J, Ruzicka E, Spackova N, Hejdukova B. Changes of event related potential and cognitive processes in patients with subclinical hypothyroidism after thyroxine treatment. Endocr Regul. 2002;36(3):115-22.
30. Baldini IM, Vita A, Mauri MC, Amodei V, Carrisi M, Bravin S, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21(6):925-35.
31. Almeida CP, Brasil MA, Costa AJL, Reis FAA, Reuters VS, Teixeira PFS, et al. Subclinical hypothyroidism: psychiatric disorders and symptoms. Rev Bras Psiquiatr. 2007;29:157-59.
32. Teixeira PFS, Reuters VS, Almeida CP, Ferreira MM, Wagman MB, Reis FAA, et al. Avaliação clínica e de sintomas psiquiátricos no hipotireoidismo subclínico. AMB Rev Assoc Med Bras. 2006;52:222-8.
33. Çakmak G, Saler T, Sadlam ZA, Yenýgün M, Demýr T. Spirometry in patients with clinical and subclinical hypothyroidism. Tuberk Toraks. 2007;55(3):266-70.
34. Koral L, Zeliha H, Cetin Y, Bilgin O, Arzu Y, Alpaslan G. Does thyroid replacement therapy affect pulmonary function tests in patients with subclinical hypothyroidism? Saudi Med J. 2006;27(3):329-32.
35. Jaeschke R, Guyatt G, Cook D, Harper S, Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Qual Life Res. 1994;3(5):323-7.
36. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of l-Thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715-23.
37. Simonsick EE, Newman AB, Ferrucci L, Satterfield S, Harris TB, Rodondi N, et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med. 2009;169(21):2011-7.
38. Park YJ, Lee EJ, Lee YJ, Choi SH, Park JK, Lee SB, et al. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch Gerontol Geriatr. 2010;50(3):e68-73.
39. Sichieri R, Baima J, Marante T, Vasconcellos MTL, Moura AS, Vaisman M. Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women. Clin Endocrinol. 2007;66(6):803-7.
40. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860-66.
41. Nyström E, Caidahl K, Fager G, Wikkelsö C, Lundberg PA, Lindstedt GA. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol. 1988;29(1):63-75.
42. Caraccio N, Natali A, Sironi A, Baldi S, Frascerra S, Dardano A, et al. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J Clin Endocrinol Metab. 2005;90:4057-62.